D-0397-2021 Class I Terminated
FDA drug recall D-0397-2021 was initiated by Acella Pharmaceuticals, LLC on Apr 29, 2021 and is designated Class I. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 13, 2024). Affected quantity: 154,726 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 2, 2021
- Initiation Date
- Apr 29, 2021
- Termination Date
- Mar 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 154,726 bottles
Product description
NP Thyroid 60 Thyroid Tablets, USP 1 grain (60 mg) 100-count bottles, Rx Only Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-330-01
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the United States including Puerto Rico
Code information
Lots: M330D20-1, M330D20-2 Exp. 03/31/2022; M330J19-2A, M330J19-4A , M330J19-5A, M330J19-6A, M330J19-7A, M330J19-9A Exp. 08/31/2021; M330K19-10, M330K19-1A, M330K19-9 Exp. 09/30/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0397-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026